Public Profile

Syneos Health, LLC

Syneos Health, LLC, a leading biopharmaceutical solutions organisation headquartered in the United States, has been at the forefront of the healthcare industry since its founding in 2018. With a strong presence in North America, Europe, and Asia, Syneos Health offers a unique blend of clinical and commercial services designed to accelerate the delivery of innovative therapies to market. The company specialises in providing integrated solutions that encompass clinical development, commercialisation, and consulting services. Syneos Health distinguishes itself through its commitment to harnessing data and technology, enabling clients to navigate the complexities of drug development efficiently. Recognised for its strategic approach, the company has achieved significant milestones, positioning itself as a trusted partner for biopharmaceutical companies worldwide.

DitchCarbon Score

How does Syneos Health, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

4

Industry Benchmark

Syneos Health, LLC's score of 25 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Syneos Health, LLC's reported carbon emissions

Syneos Health, LLC, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures on their emissions, it is challenging to assess their climate impact or commitments. However, the company is likely to be engaged in industry-standard practices aimed at reducing carbon footprints, as many organisations in the healthcare sector are increasingly prioritising sustainability. As the landscape of corporate climate commitments evolves, Syneos Health may develop and disclose future initiatives to address climate change and enhance their environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Syneos Health, LLC's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Syneos Health, LLC is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Syneos Health, LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Aptuit LLC

US
Chemicals nec
Updated 14 days ago
DitchCarbon Score

Ergomed

GB
Research and development services (73)
Updated 14 days ago

Pharmaceutical Product Development, LLC

US
Research and development services (73)
Updated 14 days ago
DitchCarbon Score

Parexel

US
Research and development services (73)
Updated about 23 hours ago

Chiltern International Limited

GB
Research and development services (73)
Updated 14 days ago
DitchCarbon Score

Icon

IE
Research and development services (73)
Updated about 23 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers